Global Opioid Receptor Agonist Market, By Drugs (Fentanyl, Codeine, Morphine, Buprenorphine, Others), Receptor Binding (Full Agonist, Partial Agonist), Indication (Pain management, Cough Suppression, Diarrhoea suppression, others), Route of Administration (Intravenous, Subcutaneous, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)-Industry Trends and Forecast to 2029.
Opioid Receptor Agonist Market Analysis and Insights
Opioids are a type of painkiller that works by acting on the neurological system. They're mostly utilized for anaesthetic and pain relief. An agonist is a pharmacological molecule that activates specific brain receptors. When only a small number of receptors are engaged, this agonist elicits a strong physiological/pharmacological response, indicating that the medication has high intrinsic activity. Fentanyl, morphine, dihydromorphinone, meperidine, oxycodone, and oxymorphone are all strong agonist opioids. Opioid receptors are G-protein-coupled inhibitors that are primarily found in peripheral tissues and interfere with opioid receptors' pain-signaling function. Agonists are pain relievers that function by binding opioid receptors and reducing pain experience.
- The rise in the aviation sector is escalating the growth of opioid receptor agonist market. Data Bridge Market Research analyses that the opioid receptor agonist market will grow at a CAGR of 4.50% during the forecast period of 2022 to 2029.
Opioid Receptor Agonist Market Dynamics
Drivers
Major factors that are expected to boost the growth of the opioid receptor agonist market in the forecast period are as follows
-
The rise in the incidence of chronic pain in adults
The number of people suffering with chronic pains is increasing rapidly. This is anticipated to drive the growth of global opioid receptor agonist market.
-
The growing cases of orthopedic diseases
Rise in the number of cases of joint replacement surgeries, such as total knee and hip replacement, is one of the major contributors to market growth.
-
The increase in the geriatric population
Growing of the elderly population which leads to complications such as orthopedic surgeries and rise in the prevalence of chronic pain are lifting the growth of the opioid receptor agonist market.
Opportunities
In addition, the growing attention on the abuse-deterrent formulation (ADF) by generic manufacturers will further provide potential opportunities for the growth of the opioid receptor agonist market in the coming years.
Restraints/Challenges
On the other hand, the initiation of generics version of branded drugs is further projected to impede the growth of the opioid receptor agonist market in the near future.
This opioid receptor agonist market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on opioid receptor agonist market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Patient Epidemiology Analysis
The opioid receptor agonist market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Covid-19 Impact on Opioid Receptor Agonist Market
The COVID-19 pandemic and the lockdown scenario in several countries worldwide have impacted the financial status of businesses across all sectors, counting the private healthcare sector. The entire supply chain of the healthcare industry has been impacted due to strict lockdown in several regions. Thus, impact of the Coronavirus has limited the growth of the opioid receptor agonist market due to decline in supply of raw materials and pharmaceutical drugs of manufacturing companies globally associated with opioids.
Recent Development
- In September 2020, Fujian Cancer Hospital introduced a phase III clinical trial to evaluate the efficiency and well-being of fentanyl patch patients with moderate cancer pain in opioid-naive patients.
- In March 2020, Trevena Inc. received the U.S. Food and Drug Administration (FDA) approval for OLINVYK (oliceridine). It is an opioid agonist indicated in adults so as to manage acute pain.
Global Opioid Receptor Agonist Market Scope
The opioid receptor agonist market is segmented on the basis of drugs, receptor binding, indication, route of administration, end users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Drugs
- Fentanyl
- Codeine
- Morphine
- Buprenorphine
- Others
On the basis of drugs, the opioid receptor agonist market is segmented into fentanyl, codeine, morphine, buprenorphine and others.
Receptor Binding
- Full Agonist
- Partial Agonist
On the basis of receptor binding, the opioid receptor agonist market is segmented into full agonist, partial agonist.
Indication
- Pain management
- Cough Suppression
- Diarrhoea suppression
- others
On the basis of indication, the opioid receptor agonist market is segmented into pain management, cough suppression, diarrhea suppression and others.
Route of Administration
- Intravenous
- Subcutaneous
- Others
On the basis of route of administration, the opioid receptor agonist market is segmented into oral, parenteral and others.
End Users
- Hospitals
- Homecare
- Specialty Clinics
- Others
On the basis of end users, the opioid receptor agonist market is segmented into hospitals, homecare, specialty clinics and others.
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
On the basis of distribution channel, the opioid receptor agonist market is segmented into hospital pharmacy, online pharmacy and retail pharmacy.
Opioid Receptor Agonist Market Regional Analysis/Insights
The opioid receptor agonist market is analysed and market size insights and trends are provided by country, drugs, receptor binding, indication, route of administration, end users and distribution channel as referenced above.
The countries covered in the opioid receptor agonist market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the opioid receptor agonist market due to the rise in the incidence of rate of cancer. Furthermore, the occurrence of major key players will further boost the growth of the opioid receptor agonist market in the region during the forecast period.
Asia-Pacific is projected to observe significant amount of growth in the opioid receptor agonist market due to the suitable reimbursement schemes. Moreover, the growing of worldwide vendors is further anticipated to propel the growth of the opioid receptor agonist market in the region in the coming years.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and Opioid Receptor Agonist Market Share Analysis
The opioid receptor agonist market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to opioid receptor agonist market.
Some of the major players operating in the opioid receptor agonist market are Teva Pharmaceutical Industries Ltd, Johnson & Johnson Services, Inc, Pfizer Inc, Fresenius Kabi AG, Mylan N.V., Allergan, US WorldMeds, LLC, Piramal Critical Care, DAIICHI SANKYO COMPANY, LIMITED, Purdue Pharma L.P., Hikma Pharmaceuticals PLC, Endo Pharmaceuticals Inc, Sun Pharmaceutical Industries Ltd, Tris Pharma, Inc and Indivior PLC among others.
SKU-
